tirzepatide semaglutide therapeutic modality and are both injectable medications used in medical weight management—but they act on different metabolic pathways, which is why patient selection matters. Semaglutide (GLP-1 receptor agonist): • Primarily targets appetite Ozempic® (semaglutide) and Mounjaro™ (tirzepatide),

Vitiligo: a focus on pathogenesis and its therapeutic implications

Its blockbuster drug, OZEMPIC (semaglutide) , transformed diabetes care, while its higher-dose counterpart, WEGOVY , became a game-changer in weight management

Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials

NTS GLP-1 neurons project on the lateral parabrachial nucleus (LPBN), and Ex-4 injection of LPBN neurons showed similar effects on both chow and high-fat food intake (Alhadeff et al., Expression of supramammillary nucleus (SuM) GLP-1R is comparable with the expression in the LH and NAc, but lower than that found in the NTS (Lpez-Ferreras et al., 2016)

These organs are known to have high concentrations of mitochondria